1 completed, 1 recruiting, 1 terminated, 1 unknown. 2 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Stable Coronary Disease: new trials by email Literature Review of Stable Coronary Disease trials Research Report on Stable Coronary Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Impact of Pcsk-9 Inhibition on PET CFR in Patients at High CV Risk Evolocumab - Stable Coronary Disease | Phase 4 | Recruiting | Brigham and Women's Hospital | 50 | 2022-03-03 | 2025-11-04 |
| Post TAVI Coronary REVASCularisation Guided by Myocardial Perfusion Imaging: a Prospective Open Label Pilot Study: The REVASC-TAVI Study TAVI procedure - Severe and Symptomatic Aortic Stenosis, Stable Coronary Disease | Not applicable | Completed | University Hospital, Montpellier | 71 | 2016-06-23 | 2025-09-30 |
| A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage Type 2 Diabetes Mellitus；, Stable Coronary Disease | Unknown | Tianjin Medical University | 144 | 2014-08-01 | 2014-08-12 | |
| Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen Drug Eluting Stent - Stable Coronary Disease, Unstable Coronary Disease | Not applicable | Terminated | CID - Carbostent & Implantable Devices | 16 | 2010-10-01 | 2018-05-07 |
Aortic Valve Stenosis (1) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1) · Myocardial Ischemia (1)
Aortic Valve Disease (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Heart Valve Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1) · Ventricular Outflow Obstruction (1)
Drug-Eluting Stents (1) · evolocumab (1)
Brigham and Women's Hospital (1) · CID - Carbostent & Implantable Devices (1) · Tianjin Medical University (1) · University Hospital, Montpellier (1)
Brazil (1) · China (1) · France (1) · Italy (1) · United States (1)
Alexandre Abizaid, Dr (1) · Diana Lopez, MD (1) · Marco Valgimigli, Dr (1) · Xiaofei Wang, doctor (1)